Literature DB >> 17452648

BetaKlotho is required for metabolic activity of fibroblast growth factor 21.

Yasushi Ogawa1, Hiroshi Kurosu, Masaya Yamamoto, Animesh Nandi, Kevin P Rosenblatt, Regina Goetz, Anna V Eliseenkova, Moosa Mohammadi, Makoto Kuro-o.   

Abstract

Fibroblast growth factor 21 (FGF21) is a liver-derived endocrine factor that stimulates glucose uptake in adipocytes. Here, we show that FGF21 activity depends on betaKlotho, a single-pass transmembrane protein whose expression is induced during differentiation from preadipocytes to adipocytes. BetaKlotho physically interacts with FGF receptors 1c and 4, thereby increasing the ability of these FGF receptors to bind FGF21 and activate the MAP kinase cascade. Knockdown of betaKlotho expression by siRNA in adipocytes diminishes glucose uptake induced by FGF21. Importantly, administration of FGF21 into mice induces MAP kinase phosphorylation in white adipose tissue and not in tissues without betaKlotho expression. Thus, betaKlotho functions as a cofactor essential for FGF21 activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452648      PMCID: PMC1855074          DOI: 10.1073/pnas.0701600104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Evolution of the Fgf and Fgfr gene families.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  Trends Genet       Date:  2004-11       Impact factor: 11.639

Review 2.  Mammalian facilitative glucose transporter family: structure and molecular regulation.

Authors:  J E Pessin; G I Bell
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

Review 3.  Structural basis for fibroblast growth factor receptor activation.

Authors:  Moosa Mohammadi; Shaun K Olsen; Omar A Ibrahimi
Journal:  Cytokine Growth Factor Rev       Date:  2005-04       Impact factor: 7.638

4.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

5.  FGF-21 as a novel metabolic regulator.

Authors:  Alexei Kharitonenkov; Tatiyana L Shiyanova; Anja Koester; Amy M Ford; Radmila Micanovic; Elizabeth J Galbreath; George E Sandusky; Lisa J Hammond; Julie S Moyers; Rebecca A Owens; Jesper Gromada; Joseph T Brozinick; Eric D Hawkins; Victor J Wroblewski; De-Shan Li; Farrokh Mehrbod; S Richard Jaskunas; Armen B Shanafelt
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

6.  Suppression of aging in mice by the hormone Klotho.

Authors:  Hiroshi Kurosu; Masaya Yamamoto; Jeremy D Clark; Johanne V Pastor; Animesh Nandi; Prem Gurnani; Owen P McGuinness; Hirotaka Chikuda; Masayuki Yamaguchi; Hiroshi Kawaguchi; Iichiro Shimomura; Yoshiharu Takayama; Joachim Herz; C Ronald Kahn; Kevin P Rosenblatt; Makoto Kuro-o
Journal:  Science       Date:  2005-08-25       Impact factor: 47.728

7.  Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.

Authors:  Shinji Ito; Toshihiko Fujimori; Akiko Furuya; Junko Satoh; Yoko Nabeshima; Yo-Ichi Nabeshima
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 8.  The phosphatonin pathway: new insights in phosphate homeostasis.

Authors:  Susan C Schiavi; Rajiv Kumar
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities.

Authors:  Omar A Ibrahimi; Fuming Zhang; Anna V Eliseenkova; Nobuyuki Itoh; Robert J Linhardt; Moosa Mohammadi
Journal:  Hum Mol Genet       Date:  2004-07-28       Impact factor: 6.150

10.  Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing.

Authors:  Zhen Y Jiang; Qiong L Zhou; Kerri A Coleman; My Chouinard; Queta Boese; Michael P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  244 in total

1.  FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model.

Authors:  Taeko Uonaga; Kentaro Toyoda; Teru Okitsu; Xiaotong Zhuang; Shunsuke Yamane; Shinji Uemoto; Nobuya Inagaki
Journal:  Islets       Date:  2010 Jul-Aug       Impact factor: 2.694

Review 2.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

3.  Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.

Authors:  Regina Goetz; Mutsuko Ohnishi; Serkan Kir; Hiroshi Kurosu; Lei Wang; Johanne Pastor; Jinghong Ma; Weiming Gai; Makoto Kuro-o; Mohammed S Razzaque; Moosa Mohammadi
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

4.  Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.

Authors:  Rikke Kruse; Sara G Vienberg; Birgitte F Vind; Birgitte Andersen; Kurt Højlund
Journal:  Diabetologia       Date:  2017-07-18       Impact factor: 10.122

5.  FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

Review 6.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

7.  Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Authors:  Tracey B Tucker Zhou; Gwendalyn D King; CiDi Chen; Carmela R Abraham
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

8.  Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.

Authors:  J M Gallego-Escuredo; J Gómez-Ambrosi; V Catalan; P Domingo; M Giralt; G Frühbeck; F Villarroya
Journal:  Int J Obes (Lond)       Date:  2014-05-12       Impact factor: 5.095

9.  Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop.

Authors:  Rucha Patel; Angie L Bookout; Lilia Magomedova; Bryn M Owen; Giulia P Consiglio; Makoto Shimizu; Yuan Zhang; David J Mangelsdorf; Steven A Kliewer; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-12-11

10.  Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones.

Authors:  Andrew C Adams; Tamer Coskun; Christine C Cheng; Libbey S O Farrell; Susan L Dubois; Alexei Kharitonenkov
Journal:  Mol Metab       Date:  2013-05-29       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.